Kirkland provided counsel to Commure, Inc., a company in the General Catalyst portfolio, in finalizing a definitive agreement for the acquisition of Augmedix, Inc., a company specializing in ambient AI medical documentation and data solutions. Commure, Inc. intends to utilize the synergies resulting from the acquisition to further expand its presence in the healthcare technology sector. The acquisition was publicly disclosed on July 19, 2024, and is expected to be completed in late Q3 or early Q4, 2024.
The team was led by corporate partner Marshall Shaffer and associates Davi Sacco and George Colligan, with assistance from corporate partners Christian Atwood and Dave Gusella.
Augmedix, Inc. (Nasdaq: AUGX) has announced that it will be acquired by Commure, Inc. in an all-cash transaction valued at approximately $139 million. Under the terms of the agreement, Augmedix stockholders will receive $2.35 per share in cash, and Augmedix will become a wholly-owned subsidiary of Commure. This acquisition represents a premium of approximately 169% over the volume weighted average price of Augmedix’s common stock for the 30 days ending July 18, 2024.
Kirkland & Ellis LLP, based in Chicago, Illinois, is a prominent American multinational law firm. Established in 1909, Kirkland & Ellis holds the title of being the largest law firm globally in terms of revenue and the seventh-largest in terms of the number of attorneys. It made history as the first law firm to achieve an annual revenue of US$4 billion.